Skip to content

High PSA and a normal MRI: what now?

What PI-RADS 1 or 2 means when the PSA is high, PSA density and when a biopsy is still on the table.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 20, 2026
Book a consultation
Drawing of a blood collection tube with an arrow pointing up, next to a dark MRI screen showing the prostate seen from above, whole and without any lesion
On this page

Quick answer

When the PSA is high and the MRI comes back PI-RADS 1 or 2, the scan showed no suspicious area. The chance of a significant cancer is low, but not zero: in a review of 42 studies, an MRI without a lesion was right in 90.8% of men who had never had a biopsy.4 The next step depends on PSA density, the rectal exam, family history and the quality of the MRI.1 In my practice, with PI-RADS 1 or 2, I always look at PSA density, but it is not the only factor: I weigh everything about the patient before deciding on a biopsy. With a density above 0.20, the decision is also case by case.

What a normal MRI means

The radiologist gives the prostate MRI a score from 1 to 5, the PI-RADS. Scores 1 and 2 mean that a significant cancer is very unlikely or unlikely. In a review of 117 studies, the chance was 3% with PI-RADS 1 and 6% with 2.2

MRI is good at finding the cancer that matters. In the PROMIS study, it picked up 93% of the significant cancers found by mapping the whole prostate.3 In a review of 42 studies with 7,321 men, 90.8% of those who had never had a biopsy and had an MRI without a suspicious lesion did not have significant cancer. The authors point out the other side: 7% to 10% had a cancer the scan did not show, and the figure varied from one center to another.4

So a normal MRI with a high PSA is reassuring, but it still needs to be read together with everything else.

Why PSA rises without a lesion on MRI

PSA is specific to the prostate, not to cancer. It rises with an enlarged prostate, prostatitis, urinary tract infection and urinary retention.1 A urinary infection can push PSA above 100 ng/mL, and it can take up to a year to return to normal.1 The test also varies from one sample to the next, by up to 15% up or down.1

Often, a high PSA simply reflects the size of the prostate. A large gland makes more PSA, even without cancer, as I explain in swollen prostate.

Before a PSA test, I ask for at least 3 days of prostate rest, with no ejaculation, cycling or rectal exam. In men taking finasteride or dutasteride, I always double the PSA value to interpret it. What else affects the result is in what affects PSA and PSA and finasteride.

PSA density

PSA density is the PSA divided by the prostate volume, which the MRI itself measures. It shows whether the PSA is high for the size of the gland. You can work it out with the PSA density calculator.

These figures come from an analysis used by the European guideline, in men who had an MRI before their first biopsy:1,5

MRI and densityRisk of significant cancer
PI-RADS 1 or 2 and density below 0.103%
PI-RADS 1 or 2 and density above 0.2018%

In a German study of 1,040 men, all had an MRI and a biopsy. When the MRI showed no suspicious lesion, the chance of no significant cancer was 79%. With a density of 0.15 or less, it rose to 89%.6

An example helps. A PSA of 6 ng/mL in an 80 mL prostate gives a density of 0.075. The same PSA in a 25 mL prostate gives 0.24. The MRI may be normal in both cases, and the conversation about a biopsy changes a great deal.

What the European guideline recommends

The European guideline places MRI as the first tool for deciding on a biopsy. With a negative MRI, it accepts skipping the biopsy and following the PSA when three conditions are present together: PI-RADS 2 or lower, PSA density below 0.20 and no prostate cancer in the family.1 It is a weak recommendation, to be decided together with the patient.

When suspicion remains high, the same guideline notes that a negative MRI is not enough, and a systematic biopsy of the whole prostate is still needed.1 A high density, an abnormal rectal exam, a fast-rising PSA and a strong family history all weigh in favor of that conversation.

MRI quality matters

A normal MRI is only reassuring if the scan is good. The European guideline asks for high-quality imaging, reading by an experienced radiologist and the option to repeat the scan when it is not adequate.1 In the review of 42 studies, the accuracy of a negative MRI varied between centers, and the authors suggest using local data when available.4

In my practice, I look at the images, not just the report. If the MRI done in the patient's home city is of very poor quality, I suggest repeating it before deciding anything.

The rectal exam and family history

The rectal exam still has a place. In my practice, an abnormal rectal exam always leads to an MRI, even with a normal PSA. The page on prostate nodules explains what the doctor feels during the exam.

Family history also changes the reading. The European recommendation to skip the biopsy applies to men without prostate cancer in the family.1 In men with a BRCA2 mutation or many cases in the family, I start PSA testing at 40 and repeat it every year, as I explain in when to start PSA testing.

If the decision is to follow up

Following up means continuing to measure PSA. A new rise, a change in the rectal exam or a lesion on a future MRI reopens the conversation about a biopsy.1

In my practice, I continue PSA testing while the man is healthy and has a life expectancy of more than 10 years. After a normal MRI, the interval until the next PSA test is decided case by case.

If a biopsy is recommended

With no lesion on MRI, the biopsy takes samples from the whole prostate, systematically.1 The European guideline recommends the transperineal route, because of its low risk of infection.1

I have performed transperineal biopsy since 2022, always under sedation, in the operating room. It takes about 20 minutes and is done without antibiotics. When the MRI shows a lesion, I use cognitive fusion: with the images at hand, I sample the lesion and the rest of the prostate. If the biopsy is negative, the next steps are in negative biopsy with a high PSA.

How I approach it

When PSA is abnormal, I go straight to a prostate MRI, without repeating the test first. I do not order free PSA routinely, nor PSA density before the MRI. After it, I always look at the density, calculated from the prostate volume. With PI-RADS 1 or 2, density is one of the factors I use, but not the only one: I add the rectal exam, family history, how the PSA has changed over time, medications and the quality of the MRI before deciding on a biopsy. With PI-RADS 3 or higher, I always recommend a biopsy, as I explain in PI-RADS 3, 4 or 5.

I have a PhD from the University of São Paulo Medical School, with a thesis on artificial intelligence for detecting and grading prostate cancer. The first consultation can be at my office in Vila Mariana or online, in English, with your test results sent in advance.

When to see a urologist

  • If your PSA is high and the MRI showed PI-RADS 1 or 2, and you want to understand the next step
  • If your PSA density is 0.15 or higher
  • If your PSA keeps rising after a normal MRI
  • If the rectal exam showed any change
  • If there is prostate cancer or a BRCA2 mutation in your family

Send your case

If you would like my opinion on your PSA and MRI before a consultation, fill in the form below. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Can a high PSA with a normal MRI still be cancer?

It can, but the chance is low. In a review of 42 studies, an MRI without a suspicious lesion was right in 90.8% of men who had never had a biopsy, and 7% to 10% had a significant cancer the scan did not show.4 In a review of 117 studies, the chance was 3% with PI-RADS 1 and 6% with PI-RADS 2.2

With PI-RADS 1 or 2, do I need a biopsy?

Not always. The European guideline accepts skipping the biopsy and following the PSA when PI-RADS is 2 or lower, PSA density is below 0.20 and there is no prostate cancer in the family, as a weak recommendation for shared decision-making.1 In my practice, with PI-RADS 1 or 2, I always look at PSA density, but it is not the only factor: I weigh everything about the patient before deciding on a biopsy, case by case, also when the density is above 0.20.

What does PSA density change?

A lot. With PI-RADS 1 or 2, the risk of significant cancer was 3% with a density below 0.10 and 18% with a density above 0.20.1,5 In a study of 1,040 men with a normal MRI, the chance of no significant cancer rose from 79% to 89% when the density was 0.15 or less.6

Why is my PSA high if the MRI is normal?

PSA is specific to the prostate, not to cancer. It rises with an enlarged prostate, prostatitis, urinary tract infection and urinary retention.1 A large prostate makes more PSA, which is why density helps to read the test.

Should I repeat the MRI?

Sometimes. The European guideline asks for high-quality imaging, experienced reading and the option of repeating the scan.1 In my practice, if the MRI done in the patient's home city is of very poor quality, I suggest repeating it.

What if my PSA keeps rising after a normal MRI?

Then the conversation opens again. With high suspicion and a negative MRI, the European guideline notes that a systematic biopsy is still needed.1 A new rise in PSA calls for reviewing the case in a consultation.

Who can review a high PSA with a normal MRI for me in Brazil?

I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I have a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic operations, more than 500 of them robotic. I read PI-RADS together with PSA density, the rectal exam and family history. When a biopsy is needed, I perform it by the transperineal route, always under sedation. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2026. EAU
  2. Nedelcu A, Oerther B, Benkendorff A, et al. PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics. A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2026;226(2):e2533583. PubMed
  3. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815-822. PubMed
  4. Sathianathen NJ, Omer A, Harriss E, et al. Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. Eur Urol. 2020;78(3):402-414. PubMed
  5. Schoots IG, Padhani AR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int. 2021;127(2):175-178. PubMed
  6. Distler FA, Radtke JP, Bonekamp D, et al. The Value of PSA Density in Combination with PI-RADS for the Accuracy of Prostate Cancer Prediction. J Urol. 2017;198(3):575-582. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides